NCT05833178

Brief Summary

Examination of blood samples is inevitable in intensive care units. Routine blood samples can be an important cause for anemia. In this study, we aimed to examine how our blood collection routine affects hemoglobin values.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

April 15, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 27, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

2 months

First QC Date

April 15, 2023

Last Update Submit

June 12, 2023

Conditions

Anemia

Keywords

Intensive care unitRoutine blood sampleOverdrawn

Outcome Measures

Primary Outcomes (1)

  • Evaluation of blood volume drawn for daily routine in intensive care

    Daily routine blood test and blood volume determination in intensive care patients

    2 months

Secondary Outcomes (1)

  • Anemia

    2 months

Interventions

Drawn Blood VolumeBEHAVIORAL

Hemoglobine Changes

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients over the age of 18 who were followed up in the intensive care unit by our clinic and treated for more than 48 hours were included in the study.

You may qualify if:

  • Patients followed in the intensive care unit for more than 48 hours, ≥18-year-old

You may not qualify if:

  • Patients not followed up by our clinic,≤18-year-old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dilan Akyurt

Samsun, 55270, Turkey (Türkiye)

Location

Related Publications (2)

  • Helmer P, Hottenrott S, Steinisch A, Roder D, Schubert J, Steigerwald U, Choorapoikayil S, Meybohm P. Avoidable Blood Loss in Critical Care and Patient Blood Management: Scoping Review of Diagnostic Blood Loss. J Clin Med. 2022 Jan 10;11(2):320. doi: 10.3390/jcm11020320.

    PMID: 35054014BACKGROUND

  • Siegal DM, Manning N, Jackson Chornenki NL, Hillis CM, Heddle NM. Devices to Reduce the Volume of Blood Taken for Laboratory Testing in ICU Patients: A Systematic Review. J Intensive Care Med. 2020 Oct;35(10):1074-1079. doi: 10.1177/0885066618810374. Epub 2018 Nov 27.

    PMID: 30482081BACKGROUND

Related Links

MeSH Terms

Conditions

Anemia

Condition Hierarchy (Ancestors)

Hematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Mustafa SÜREN

    Samsun University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Specialist of Anaesthesiology and Reanimasion

Study Record Dates

First Submitted

April 15, 2023

First Posted

April 27, 2023

Study Start

April 1, 2023

Primary Completion

May 30, 2023

Study Completion

May 31, 2023

Last Updated

June 15, 2023

Record last verified: 2023-06

Locations

TU(1)